ProtAffin's Series B Round

ProtAffin raised a round of funding on April 08, 2009.

ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures that drive inflammatory processes…

Articles about ProtAffin's Series B Round: